Stay updated on Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial
Sign up to get notified when there's something new on the Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial page.

Latest updates to the Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial page
- Check5 days agoChange DetectedThe footer's site revision indicator changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check12 days agoChange DetectedThe ClinicalTrials.gov site revision indicator changed from v3.7.0 to v3.7.1; the study record content remains unchanged.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe study history now includes additions of Adverse Events, Outcome Measures (Results), Baseline Characteristics, and Participant Flow as part of the Document Section updates, tied to revision v3.7.0 (38) around 2026-09-15 to 2026-09-18.SummaryDifference0.9%

- Check54 days agoChange DetectedNew revision label v3.6.6 appears in the record history, and the previous revision v3.6.5 is removed. This indicates the study record history has been updated to reflect the latest version of the record.SummaryDifference0.1%

- Check75 days agoChange DetectedA new revision entry v3.6.5 was added to the study record history, and the previous revision v3.6.4 was removed, updating the page's version history to reflect the latest changes.SummaryDifference0.1%

- Check90 days agoChange DetectedThe study history now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3.SummaryDifference0.1%

Stay in the know with updates to Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial page.